Archive for the 'Pericardial' Category
December 23rd, 2008. Malignant mesothelioma
Compensation issues must also be considered. Life expectancy in malignant mesothelioma is poor, with a median survival of about one year following diagnosis.
Posted in Benign, CT or CAT scan, Causation, Diagnosis & Differentiation, Environmental Asbestos Exposure, Full Archive, General, Occupational Asbestos Exposure, Pericardial, Peritoneal (Abdominal Mesothelioma), Pleural, Survival, Symptoms & Symptom Management, Treatment, Trimodality Therapy, Tunica Vaginalis Testis, Type of Assessment:, Type of Mesothelioma: | No Comments »
July 10th, 2008. Localized malignant mesothelioma in the middle mediastinum: Report of a case
We assumed that the tumor was derived from the pericardium. Local recurrence was detected 1 year after resection, and the patient died of the disease about 2 years later.
June 4th, 2008. Pulmonary Paragonimiasis with Coincidental Malignant Mesothelioma
Here, we report a very rare case of malignant mesothelioma with a concomitant infection of parasitic lung fluke. Keywords: paragonimiasis, malignant mesothelioma, eosinophilia.
April 16th, 2008. Activity of the Campania Register of Mesothelioma from july 2003 to October 2007
16%), Ship building (7. 5%).
Posted in Causation, Epidemiological, Full Archive, General, Occupational Asbestos Exposure, Pericardial, Peritoneal (Abdominal Mesothelioma), Pleural, Tunica Vaginalis Testis, Type of Assessment:, Type of Mesothelioma: | No Comments »
February 19th, 2008. Pericardial malignant mesothelioma: a latent complication of radiotherapy?
Radiotherapy and asbestos exposure are both associated with pericardial mesothelioma and the aetiology in this case was not clear. The condition carries a poor prognosis and is invariable fatal although newer chemotherapeutic regimens have prolonged survival times.
Posted in Carboplatin, Case Study, Chemotherapy, Diagnosis & Differentiation, Full Archive, Pemetrexed (Alimta), Pericardial, Radiation, Survival, Treatment, Type of Assessment:, Type of Mesothelioma: | No Comments »
October 16th, 2007. Primary pericardial mesothelioma
The patient died 16 months after diagnosis. New cytotoxic drugs can improve the prognosis of this rare entity.
October 3rd, 2007. Malignant mediastinal tumor with bone formation–mesothelioma or sarcoma?
However, the tumor grew rapidly and spread to the pleura, involved the heart, and the patient succumbed. This is to our knowledge the first report of a sarcomatous mesothelioma with bone formation from environmental exposure to mineral fibers.
Posted in Carboplatin, Case Study, Chemotherapy, Diagnosis & Differentiation, Full Archive, Pemetrexed (Alimta), Pericardial, Pleural, Sarcomatoid, Surgery, Treatment, Tumor Debulking, Type of Assessment:, Type of Mesothelioma: | No Comments »
September 1st, 2007. Report of a Case of Pericardial Mesothelioma with Liver Metastases Responding Well to Pemetrexed and Platinum-Based Chemotherapy
com Abstract Pericardial mesothelioma remains a disease with a bleak prognosis. We report the case of a patient with metastases to liver and good response to pemetrexed and carboplatin-based combination chemotherapy and consequent prolonged progression-free survival.
Posted in Carboplatin, Case Study, Chemotherapy, Determining Efficacy, Full Archive, Pemetrexed (Alimta), Pericardial, Survival, Treatment, Type of Assessment:, Type of Mesothelioma: | No Comments »
November 30th, 2006. Disseminated Intravascular Coagulopathy Caused by Intracardiac Mesothelioma
Her symptoms were completely relieved by emergency resection of the tumor. Primary resection of the intracardiac mesothelioma is adequate treatment for this complicated surgical problem.
October 7th, 2006. Sarcomatous pleural mesothelioma metastatic to left ventricular endocardium
Abstract A 71-year-old man, a cigarette smoker with long-term asbestos exposure, developed multifocal malignant sarcomatous pleural mesothelioma that metastasized to the left ventricular endocardium without invading pericardium, myocardium, or the contiguous pulmonary vein. This is the first reported case of malignant pleural mesothelioma to metastasize in such a manner.
September 29th, 2006. Recurrent pericardial effusion as initial manifestation of primary diffuse pericardial malignant mesothelioma
Diffuse malignant pericardial mesothelioma was diagnosed after mediastinal mass biopsy. The patient underwent further oncological evaluation followed by chemotherapy.
June 21st, 2006. D2-40: A Reliable Marker in the Diagnosis of Pleural Mesothelioma
Conclusions: We regard D2-40 as a valid marker in the differential diagnosis of epithelioid mesotheliomas versus pulmonary adenocarcinomas. However, this marker may not properly label sarcomatoid mesotheliomas or distinguish them from reactive pleural lesions.
June 8th, 2006. Pericardial mesothelioma in a neonatal calf
Immunohistochemistry revealed that they had the characteristics of mesothelial cells (cytokeratin-and vimentin-positive), and the neoplasm was diagnosed as mesothelioma. Keywords: congenital tumor, neonatal calf, pericardial mesothelioma.
May 5th, 2006. Canine cardiac mesothelioma with granular cell morphology
At 4 months after thoracotomy, pericardectomy, and mass excision, this dog was alive and without clinical evidence of pericardial or abdominal effusions. We describe a granular morphologic variant of cardiac mesothelioma in a dog.
March 13th, 2006. Triplet Chemotherapy for Malignant Pericardial Mesothelioma: A Case Report
The patient experienced no severe non-hematological or hematological toxicities except for grade 3 neutropenia. The patient has returned to her usual activities and has remained well for 24 months after the last chemotherapy without any evidence of disease progression.
Posted in Case Study, Chemotherapy, Cisplatin (Platinol ®), Diagnosis & Differentiation, Full Archive, Gemcitabine (Gemzar), Pericardial, Treatment, Type of Assessment:, Type of Mesothelioma:, Vinorelbine | No Comments »
February 8th, 2006. Peculiar features of mesothelioma occurrence as related to exposure patterns and circumstances in the Lombard Region, Italy
Conclusions: The high proportion of cases with unknown exposure underlines the need to explore new tools and sources to ascertain asbestos exposure. An ad hoc survey in textile industries showed exposure to asbestos to be widely spread in this industry.
December 21st, 2005. Severe right-ventricular heart failure due to malignant pericardial mesothelioma
Abstract A case of a 63-year old female with symptomatic advanced right-ventricular (RV) heart failure due to malignant pericardial mesothelioma is presented. Echocardiography revealed that RV failure was due to the tumour-induced compression of the right atrium and not due to metastatic mesothelioma involving pericardial sac.
May 1st, 2005. Malignant pericardial mesothelioma. Report of two cases, review of the literature and differential diagnosis
The median survival from the onset of symptoms is six months. In this paper we report two cases of patients with primary mesothelioma of the pericardium without a definite history of asbestos exposure.
April 1st, 2005. An autopsy case of primary pericardial mesothelioma in arc cutter exposed to asbestos through talc pencils
Subsequent transmission electron microscopic examination equipped with an energy dispersive X-ray analyzer revealed that the fibers identified in the lungs were fibrous talc and actinolite. These findings suggested that this patient had been occupationally exposed to asbestos contaminated in the talc pencils, which induced the development of primary pericardial mesothelioma.
February 16th, 2005. Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B
Conclusion: Single-agent irinotecan in this dose and schedule has considerable toxicity in patients with malignant mesothelioma and has no anti-tumor activity. The relatively long median survival seen in this study principally reflects the prognostic features of the accrued patients.
|
|  |
